Book Online
or Call 1-855-SAUSALITO
Sign In
|
Register
|
About Sausalito
|
Contact Us
Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast
|
Traffic
Online Reservations
Cavallo Point
Casa Madrona
The Gables Inn
Mill Valley Inn
Acqua Hotel
Larkspur Hotel
Waters Edge
The Lodge at Tiburon
Sausalito Hotels
Vacation Packages
San Francisco Hotels
Event Calendar
Art Galleries
Arts and Culture
Amusement Parks
Nightlife
Attractions
Sausalito Ferry
Public Parks
Entertainment
Movie Show Times
TV Listings
Celebrities on TV
Museums and Historical Places
Environmental
Food and Wine
Day Trips
Visit San Francisco
Spas and Massage
Apartments
Arts, Culture, & Entertainment
Amusement and Water Parks
Art Galleries & Dealers
Art Instruction & Schools
Attractions
Environmental
Food and Wine Entertainment
Marin Arts and Culture
Movie Theaters & Movie Rentals
Museums
Music Venues
Photographers
Photography - Commercial
Automotive
Auto Glass & Detailing
Auto Repair Service
Gas Stations
New & Used Car Dealers
Boating
Boat Rides
Boat Storage
Boats & Chartered Boats
Harbors, Marinas & Yacht Clubs
Private Yacht Clubs
Business & Professional Services
Employment Agencies
Industrial Supplies & Services
Insurance Agents & Agencies
Mailing & Shipping
Photography - Commercial
Private Investigators
Rubbish & Garbage Removal
Security Systems
Self Storage
Community & City Services
Chamber of Commerce
City & County Government
City Hall
City Maps & Guides
City of Sausalito
Community Centers
Fire Department
Library
Police Department
Post Offices
State Government
Construction and Contractors
Architects
General Contractors
Home Remodeling
Landscaping
Plumbers
Education and Schools
Nursery Schools & Kindergarten
Private Schools
Public Schools
Tutoring
Financial and Legal Services
Accountants & Tax
Banks
Bookkeeping
Financial Consultants
Lawyers & Attorneys at Law
Public Notaries
Health & Child Care
Acupuncture / Alternative Medicine
Child Protective Services
Chiropractors
Day Care
Dentists
Doctors, Physicians & Surgeons
Eye Care
Health Care Professionals
Home Health Care
Hospitals & Clinics
Hypnotherapy
Medical Equipment
Physical Therapists
Psychiatrists & Therapists
Specialists
Home and Garden
Cleaning Services
Doors & Windows
Floor Coverings
Interior Design
Landscaping
Moving Companies
Pools, Spas & Saunas
Remodeling
Media
Local TV Stations
Magazine Publishers
Newspapers
Online Publications
Print Publications
Radio Stations
Nightclubs & Music
Organizations, Foundations, & Associations
Business/Professional
Charitable Foundations
Common Interest Groups
Non-Profits
Youth Organizations
Pets
Dog & Cat Grooming
Kennels & Pet Boarding
Pet Hospitals
Pet Supplies
Veterinarians
Real Estate
Apartments
Appraisers
Commercial Development
Commercial Management
Commercial Real Estate
Construction
Developers
Mortgage Brokers
Property Management
Residential Real Estate
Religion
Restaurants, Food & Bars
American
Bakery
Breakfast
Burgers
Chinese
Coffee & Caf�s
Deli
Fast Food
Free Wi-Fi
French
Himalayan
Ice Cream / Frozen Yogurt
Indian
Italian
Mexican
Ocean View Restaurants
Pizza
Seafood
Sports Bars
Steakhouse
Sushi
Thai Food
Wine Tasting Room
Salons, Spas, & Fitness
Barbers
Beauty Salons
Cosmetics
Fitness Equipment
Gyms & Health Clubs
Manicures & Pedicures
Massages
Personal Trainers
Spas
Waxing
Sausalito Hotels & Inns
Bed & Breakfasts
Hotels, Motels & Resorts
Vacation Rentals
Shopping
Book Stores
Children's Clothing
Electronics
Florists
Furniture & Appliances
Gifts & Specialty Shops
Grocery Stores
Handbags
Jewelers
Marin County Shopping Centers
Men & Women's Clothing
Men's Clothing
Shoes
Sportswear
Women's Clothing
Yoga
Sports and Recreation
Bicycle Rentals & Retailers
Boats & Chartered Boats
Kayaking
Public Parks
Walking Trails
Technology & Utility Services
Computer Parts & Supplies
Computer Repair
Electric Companies
Internet Service Providers
Telephone & Cable Companies
Website Development & Design
Travel and Transportation
Airport Transportation
Bike Rentals
Buses Charter & Rental
Ferry
Limo Car Services
Taxi Cabs
Travel Agencies
Weddings
Caterers
Planners
Venues
Wi-Fi Hotspots
Your Business Here
Ferry Schedule
Surf Report
Coupons
Contests
Classifieds
Site Forums
Photo Gallery
Story Archives
Advertise With Us
Free Email
Send Flowers
Search Hotels in Sausalito
CHECK-IN:
CHECK-OUT:
ROOMS:
1
2
3
4
Find A Business
or
Browse Listings
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Exelixis, Inc.
< Previous
1
2
3
4
Next >
Exelixis and Iconic Therapeutics Amend Option and License Agreement for XB002, an Antibody-Drug Conjugate Targeting Tissue Factor
January 06, 2022
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis Announces Enrollment Completion in Phase 3 CONTACT-03 Pivotal Trial of Cabozantinib in Combination with an Immune Checkpoint Inhibitor in Previously Treated Metastatic Renal Cell Carcinoma
January 05, 2022
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis to Present at the Virtual 40th Annual J.P. Morgan Healthcare Conference on January 10, 2022
January 04, 2022
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis Appoints Vicki L. Goodman, M.D., as Executive Vice President, Product Development & Medical Affairs, and Chief Medical Officer
January 04, 2022
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis Elects Jacqueline Wright to Its Board of Directors
December 17, 2021
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis Announces Initiation of Phase 1b Trial Evaluating XL092 in Combination with Immuno-oncology Therapies in Patients with Advanced Solid Tumors
December 15, 2021
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis Announces Detailed Results from Phase 3 COSMIC-312 Pivotal Trial of Cabozantinib in Combination with an Immune Checkpoint Inhibitor in Patients with Previously Untreated Advanced Liver Cancer at ESMO Asia Virtual Oncology Week 2021
November 20, 2021
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis Announces Enrollment Completion in Phase 3 CONTACT-01 Pivotal Trial of Cabozantinib in Combination with an Immune Checkpoint Inhibitor in Previously Treated Metastatic Non-Small Cell Lung Cancer
November 09, 2021
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis to Webcast Fireside Chats as Part of Virtual Investor Conferences in November and December
November 03, 2021
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis Announces Third Quarter 2021 Financial Results and Provides Corporate Update
November 02, 2021
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis to Release Third Quarter 2021 Financial Results on Tuesday, November 2, 2021
October 19, 2021
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis and STORM Therapeutics Enter into Exclusive Collaboration and License Agreement to Discover and Develop Inhibitors of Novel RNA Modifying Enzymes
October 14, 2021
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis In-Licenses Second Anti-Cancer Compound from Aurigene Following FDA Acceptance of Investigational New Drug Application for Phase 1 Clinical Trial in Non-Hodgkin’s Lymphoma
October 14, 2021
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis Announces Final Results from Phase 3 COSMIC-311 Pivotal Trial of CABOMETYX® in Patients with Previously Treated Radioactive Iodine-Refractory Differentiated Thyroid Cancer Presented at ESMO 2021
September 20, 2021
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis Announces Detailed Phase 1b Results from Cohort 6 of COSMIC-021 Trial in Patients with Metastatic Castration-Resistant Prostate Cancer Presented at ESMO 2021
September 18, 2021
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis Announces U.S. FDA Approval of CABOMETYX® (cabozantinib) for Patients with Previously Treated Radioactive Iodine-Refractory Differentiated Thyroid Cancer
September 17, 2021
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis Announces CABOMETYX® in Combination with OPDIVO® Provides Efficacy Benefits Regardless of Prior Nephrectomy in Patients with Previously Untreated Advanced Renal Cell Carcinoma Based on CheckMate -9ER Analysis Presented at ESMO 2021
September 16, 2021
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis Statement on the Passing of Two Senior Executives
September 06, 2021
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis to Webcast Fireside Chats as Part of Virtual Investor Conferences in September
September 01, 2021
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis Announces Partner Takeda and Ono Receive Approval in Japan for CABOMETYX® (cabozantinib) in Combination with OPDIVO® (nivolumab) for the Treatment of Unresectable or Metastatic Renal Cell Carcinoma
August 25, 2021
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis and Invenra Expand Collaboration to Discover and Develop Novel Biologics in Oncology
August 16, 2021
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis Announces Second Quarter 2021 Financial Results and Provides Corporate Update
August 05, 2021
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis Announces U.S. FDA Accepts for Priority Review the Supplemental New Drug Application for CABOMETYX® (cabozantinib) for Patients with Previously Treated Radioactive Iodine-Refractory Differentiated Thyroid Cancer
August 05, 2021
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis to Release Second Quarter 2021 Financial Results on Thursday, August 5, 2021
July 22, 2021
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis to Present at the Virtual William Blair Biotech Focus Conference on July 15, 2021
July 08, 2021
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis Chief Medical Officer Gisela M. Schwab, M.D., to Take Medical Leave of Absence
June 18, 2021
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis Announces Clinical Trial Collaboration and Supply Agreement with Bristol Myers Squibb to Evaluate XL092 in Combination with Immuno-oncology Therapies in Advanced Solid Tumors
June 14, 2021
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis Announces Consistent Efficacy Benefits Across Subgroups of Phase 3 CheckMate -9ER Trial of CABOMETYX® (cabozantinib) in Combination with OPDIVO® (nivolumab) as a First-line Treatment for Patients with Advanced Renal Cell Carcinoma
June 04, 2021
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis Announces Positive Phase 2 Results for CABOMETYX® (cabozantinib) in Combination with OPDIVO® (nivolumab) in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma at ASCO 2021
June 04, 2021
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
Exelixis Announces Quality-Adjusted Survival Benefit Demonstrated in Analysis of Phase 3 CheckMate -9ER Trial of CABOMETYX® (cabozantinib) in Combination with OPDIVO® (nivolumab) in Patients with Previously Untreated Advanced Renal Cell Carcinoma
June 04, 2021
From
Exelixis, Inc.
Via
Business Wire
Tickers
EXEL
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
About Us
|
Contact Us
|
Privacy Policy
|
User Agreement
|
Advertise With Us
|
Site Map
Sausalito Home
|
Lodging
|
Sausalito Restaurants
|
Things To Do
|
Sausalito Events Calendar
|
Shopping
|
Sausalito Real Estate
|
Sausalito Directory Listings
|
Sausalito Blog
|
Jobs
|
More
Photos copyright by
Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.